Was betrifft es? Warum ist das wichtig?

The aim of a Scientific Publication (SP) is to:

  • Make scientific discoveries and progress available to the research community
  • Make study results available to the general public
  • Provide data for further research

 

Researchers have an ethical obligation to make their study results public, whether they are positive, negative or inconclusive. Unpublished research is unethical as potential future study participants may become exposed to unnecessary known risks. In addition, it is a waste of valuable resources and scientific experience.

 

Thus, based on the requirements for research transparency, researchers are responsible to publish their research results. Aa a minimum requirement, results must be made available in:

  • A study relevant registry(ies), such as:
    • A primary registry recognized by the WHO (ICTRP registry network)
    • The registry of the U.S: National Library of Medicine (clinicaltrials.gov)
  • A supplementary federal database (KOFAM)

Was muss ich befolgen?

As a SP-INV of a scientific publication:

  • Decide authorship early on, and ensure authors have no conflict of interest
  • Include experts supporting the write-up of your publication (e.g. statistician, medical reviewer)
  • Favour scientific peer-reviewed journals targeting research communities of interest
  • Publish in journals where research results are available online with licenses aimed at promoting reuse (e.g. no charge, less copyright restrictions)
  • Adhere to defined publication agreements (e.g. inclusion of publication partner(s), authorship contribution, publication guidelines)

 

When publishing your research:

  • Report a summary of your results in a clear, comprehensive, unbiased and honest manner
  • Communicate valuable “lessons learned
  • Grant data access to those who may benefit from your study results (i.e. data sharing)
  • As applicable, inform study participants of your study results

 

 

In order for the general public to gain access to your research results, a publication on a supplementary federal database requires that you use a (several) Swiss national language(s)

Wo kann ich Hilfe anfordern?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

External Links

Swissethics – see in particular

  • RAPS Registry, a database of all projects approved by the ethics committees in Switzerland

Declaration of Helsinki – see in particular principle

  • 36 Publication of results

SAMS Research with human subjects – see in particular chapter

  • Chapter 11 Publication of study results

ICMJE – See in particular

  • Clinical trials recommendation

Swiss and international registries:

Swiss Law

HRA - see in particular article

  • Art. 56. Registration

ClinO – see in particular articles and annex

  • Art. 64 Approved registers and data to be entered
  • Annex 5
    • 1. Data to be entered in a register
    • 2. Data to be entered in the supplementary database
  • Art. 65 Time of registration
  • Art. 66 Responsibility
  • Art. 67 Portal: public access to clinical trials in Switzerland

ClinO-MD – See in particular articles

  • Art. 41 Registration
  • Art. 42 Publication of results
Abkürzungen
  • ClinO – Clinical Trials Ordinance
  • ClinO-MD – Ordinance on Clinical Trials with Medical Devices
  • CTU – Clinical Trials Unit
  • EC – Ethics Committee
  • EudraCT – European Union Drug Regulating Authorities Clinical Trials Database
  • HRA – Human Research Act
  • ICMJE – International Committee of Medical Journal Editors
  • KOFAM – Coordination Portal for Human Research
  • RAPS – Registry of all Projects in Switzerland
  • SAMS – Swiss Academy of Medical Sciences
  • SP-INV – Sponsor Investigator
  • RA – Regulatory Authorities
  • WHO – World Health Organization
Completion ↦ Management ↦ Publishing ↦ Scientific Publications
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Completion ↦ Management ↦ Publishing ↦ Scientific Publications

Please note: the Easy-GCS tool is currently under construction.